ADMA: ADMA Biologics Inc Kompaniya qiymatining sof foydaga nisbati
ADMA Biologics xomashyo yig'ish markazlari va patentlariga egalik qiladi, bu esa raqobatchilar uchun kirish to'siqlarini yaratadi. Daromadlar immunotegishli yetishmovchiliklar terapiyasi uchun shifoxonalarga antitelalar yetkazib berishga asoslangan. Immunoglobulinlarning muvaffaqiyati likvidlik ortiqchaligi va marjaning o'sishini ta'minladi. Kompaniyaning P/E vaqtlar ketma-ketligi ushbu fundamental ko'rsatkichlarni tasdiqlaydi, 15.50 esa joriy metrika qiymatini shakllantirib, biznes qiymatini foydaga nisbatan baholash imkonini beradi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_ADMA_-_ADMA-Biologics_-_PE-Multiple "ADMA: ADMA Biologics Biznesning o‘zini qoplash muddati 04.07.2022 - 11.11.2026 | 👁️GURU.Markets👁️")
ADMA Bio (ADMA) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati ADMA Biologics|ADMA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ADMA Corp|ADMA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati ADMA Biologics, Inc.|ADMA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz ADMA Biologics|Tezkor likvidlik koeffitsiyenti admabiologics.com
- foyda va bozor multiplikatorlari tafsilotlari:
ADMA - Sof foyda|Sof foyda prognozi ADMA Biologics|ADMA - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati ADMA Biologics Inc|ADMA - PEG multiplikatori|EV/EBITDA multiplikatori ADMA Biologics, Inc.|ADMA - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda ADMA Biologics|ADMA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi admabiologics.com|ADMA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi ADMA Biologics
Kompaniyaning har tomonlama tahlili:admabiologics.com ADMA
P/E koeffitsiyenti ADMA Biologics (ADMA) kompaniyasining bozor kapitalizatsiyasini uning sof foydasiga nisbatan bog'laydi va investorlar nazarida joriy daromadning bir dollari narxini o'lchaydi. Foyda o'sishiga bo'lgan yuqori kutuvlar bu yerda plazma yig'ish markazlariga operatsion bog'liqlik va raqobat bosimi bilan to'qnashadi, bu esa immunoglobulin ishlab chiqarishda xavflar yuzaga kelgan taqdirda kompaniyaning P/E qiymatini aktivlarning haddan tashqari qimmat baholanganligining asosiy ko'rsatkichiga aylantiradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori PTGX (Protagonist Therapeutics Inc)|Biznesning o‘zini qoplash muddati Immunovant Therapeutics (IMVT)|KNSA - Narxning foydaga nisbati|grifols.com (GRFS) - Narx-foyda koeffitsiyenti|Adaptive Biotechnologies Corporation (ADPT) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Celldex Therapeutics Inc|Narx-foyda koeffitsiyenti AUPH|P/E multiplikatori BioCryst Corp|Narxning foydaga nisbati Vera Therapeutics, Inc. (VERA)|dianthustx.com - Narx-foyda multiplikatori|P/E multiplikatori PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalizatsiyaning foydaga nisbati|Tourmaline Corp - P/E multiplikatori|PGEN - P/E multiplikatori|PHAR: P/E multiplikatori|Narx-foyda multiplikatori NKTR|Narxning foydaga nisbati Upstream Bio|Narx-foyda koeffitsiyenti Zenas Bio (ZBIO)|P/E multiplikatori IMNM|P/E multiplikatori Gossamer Bio Corp. (GOSS)|KalVista Pharmaceuticals - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati SEPN|Pieris Pharmaceuticals, Inc. - P/E multiplikatori|SVRA: Narxning foydaga nisbati|RIGL: P/E multiplikatori|ANAB - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Astria Therapeutics|Kapitalizatsiyaning foydaga nisbati engene.com ENGN|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|Narxning foydaga nisbati JBIO (aerovatetx.com)|Narxning foydaga nisbati Aclaris ACRS|Kyverna Therapeutics, Inc (KYTX) - Kapitalizatsiyaning foydaga nisbati|Tiziana Life Sciences - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti cabalettabio.com (CABA)|VTYX: P/E multiplikatori|THTX - Biznesning o‘zini qoplash muddati|AVTX (Avalo Therapeutics Inc.) - P/E multiplikatori|Narx-foyda koeffitsiyenti Eledon Pharmaceuticals, Inc (ELDN)|Narxning foydaga nisbati Agenus (AGEN)|Biznesning o‘zini qoplash muddati climbbio.com|P/E multiplikatori ZURA (Zura Bio)|P/E multiplikatori aTyr Pharma Inc ATYR|Adagene Corp - P/E multiplikatori|IMA (ImageneBio Inc) - Narx-foyda multiplikatori|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Equillium|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|P/E multiplikatori Immunic Inc|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|IFRX: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori XFOR (X4 Pharmaceuticals)|Kompaniya qiymatining sof foydaga nisbati ACET|Celularity Corp - P/E multiplikatori|INMB - P/E multiplikatori|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Kezar Life Sciences Inc - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati SAB Biotherapeutics|Narx-foyda koeffitsiyenti akaritx.com (AKTX)|P/E multiplikatori ENLV|P/E multiplikatori q32bio.com (QTTB)|GeoVax Labs Inc - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati EDSA|iBio, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati Carisma Therapeutics CARM|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|Narx-foyda koeffitsiyenti AIM (AIM ImmunoTech Inc.)|P/E multiplikatori aditxt.com (ADTX)|Narxning foydaga nisbati GRI Bio GRI|XRTX: Narx-foyda multiplikatori|ReShape Lifesciences - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Revelation Biosciences Corp|INDP: P/E multiplikatori|scinai.com (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|Narx-foyda multiplikatori AFMD (Affimed Therapeutics)|Narxning foydaga nisbati Allakos Inc. (ALLK)|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|P/E multiplikatori IGMS (IGM Biosciences)|P/E multiplikatori iteostherapeutics.com ITOS|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) Plc)|THRD: P/E multiplikatori
